Document is current
Any future updates will be listed below
-
Authors
Botana López, Manuel https://orcid.org/0000-0002-3825-6111
Camafort Babkowski, Miguel https://orcid.org/0000-0002-8669-6410
Campuzano Ruiz, Raquel
Cebrián Cuenca, Ana https://orcid.org/0000-0003-3710-6370
Gargallo Fernández, Manuel https://orcid.org/0000-0001-8646-3863
David de Paz, Héctor https://orcid.org/0000-0002-4190-5063
Redondo-Antón, Jennifer https://orcid.org/0000-0003-2661-5866
Artime, Esther https://orcid.org/0000-0003-4294-6462
Díaz-Cerezo, Silvia https://orcid.org/0000-0001-6351-818X
Rubio de Santos, Miriam https://orcid.org/0000-0001-7393-6334
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 11 March 2024
Accepted: 24 June 2024
First Online: 22 July 2024
Declarations
:
: Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, and Miriam Rubio de Santos are employees and minor shareholders of Eli Lilly and Company. Manuel Botana López, Miguel Camafort Babkowski, Raquel Campuzano Ruiz, Ana Cebrián Cuenca, Manuel Gargallo Fernández, and Héctor David de Paz declare no conflict of interest.
: The study was submitted to the Ethics Committee of 12 de Octubre Hospital (Madrid, Spain), which judged that, due to the nature of the study, further approval was not required. All participating physicians were aware of the objectives of the study, and that the results of this study would be published. Participants were identified and invited to participate through their respective scientific medical societies, and their views were independent and confidential. Participants were asked to complete the questionnaire according to their perceptions of their daily practice environment within their specialty, and not reflecting their own personal clinical practice. Participation was agreed in writing. Data were de-identified to protect the privacy of the participants.
